Crewe Advisors LLC

SEC CIK: 0001730033
Latest filing: Jul 23, 2026

SEC filings (opens in a new tab)

CPRX holding history

Catalyst Pharmaceuticals, Inc. in every 13F filed by Crewe Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CPRX overview All 13F holders of CPRX Full Q2 2026 holdings

Shares (Q2 2026): 1
Value: $32
% of portfolio: <0.1%
Quarters held: 5; Since Q2 2025

Holdings of CPRX by Crewe Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	1	$32	<0.1%	00.0%	Unchanged	Holders
Q1 2026	1	$25	<0.1%	00.0%	Unchanged	Holders
Q4 2025	1	$24	<0.1%	00.0%	Unchanged	Holders
Q3 2025	1	$20	<0.1%	00.0%	Unchanged	Holders
Q2 2025	1	$22	<0.1%	+1	New	Holders